1728-8800

CARDIOVASCULAR THERAPY AND PREVENTION

Silicea - Poligraf, LLC

View prefix report (10.15829)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 706 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact706 DOIs
2

Add abstracts to 549 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact549 DOIs
3

Deposit reference lists for 392 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact392 DOIs

DOIs for this ISSN

Showing the top 5 of 1849 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RU… (10.15829/1728-8800-2014-6-4-11)
References ORCID License
169.68 182
2 AWARENESS AND TREATMENT SPECIFICS OF STATIN THERAPY IN PERSO… (10.15829/1728-8800-2016-4-29-37)
Abstract References ORCID
110.78 29
3 COMORBIDITY: HISTORY, RECENT VIEWS, PREVENTION AND TREATMENT (10.15829/1728-8800-2015-2-74-79)
Abstract References ORCID
102.13 22
4 Syndrome of increased epithelial permeability in clinical pr… (10.15829/1728-8800-2021-2758)
Abstract References
97.47 88
5 SELECTED PARAMETERS OF CHRONIC SOCIAL STRESS IN OPEN POPULAT… (10.15829/1728-8800-2014-6-28-31)
Abstract ORCID License
88.21 14
6 CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CON… (10.15829/1728-8800-2014-6-3-8)
ORCID License
87.41 55
7 POLYMORBIDITY: SPECIFICS OF CO-DEVELOPMENT AND CONCOMITANCE… (10.15829/1728-8800-2016-4-4-9)
Abstract ORCID
68.09 22
8 ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD:… (10.15829/1728-8800-2014-4-4-14)
ORCID
57.42 197
9 Cardiovascular prevention: development strategies (10.15829/1728-8800-2011-3-5-7)
References ORCID
55.70 12
10 PRAVASTATIN IN CORRECTION OF VESSEL WALL ANTIPLATELET CONTRO… (10.15829/1728-8800-2014-6-18-22)
ORCID License
52.07 10
11 XXX RUSSIAN NATIONAL CONGRESS "MAN AND MEDICINE". APRIL 10-1… (10.15829/1728-8800-2023-6s)
References ORCID
52.07 10
12 2022 Prevention of chronic non-communicable diseases in Of t… (10.15829/1728-8800-2022-3235)
ORCID
51.70 116
13 RUSSIAN EXPERT SYSTEM ORISKON – ASSESSMENT OF THE MAJOR NON-… (10.15829/1728-8800-2013-4-51-55)
Abstract ORCID
47.71 8
14 XXIX Российский национальный конгресс «Человек и лекарство».… (10.15829/1728-8800-2022-s2)
References ORCID
45.15 7
15 Demographic trends in the Russian Federation: the impact of… (10.15829/1728-8800-2012-1-5-10)
ORCID
42.47 49
16 ASSOCIATION BETWEEN THE DEGREE OF CORONARY ATHEROSCLEROSIS,… (10.15829/1728-8800-2013-1-40-45)
Abstract ORCID
42.25 6
17 REGIONAL SPECIFICS OF CARDIOVASCULAR MORBIDITY AND MORTALITY (10.15829/1728-8800-2016-4-66-69)
Abstract ORCID
42.25 6
18 Economic burden of cardiovascular disease in the Russian Fed… (10.15829/1728-8800-2011-4-4-9)
ORCID
41.57 45
19 Adherence to a healthy lifestyle of the Russian population d… (10.15829/1728-8800-2020-2452)
Abstract
41.09 43
20 REGISTERS IN CARDIOLOGY: THEIR PRINCIPLES, RULES, AND REAL-W… (10.15829/1728-8800-2013-1-4-9)
ORCID
40.32 40
21 Persistent dyslipidemia in statin-treated patients: Russian… (10.15829/1728-8800-2012-4-70-78)
ORCID
38.91 35
22 ASSOCIATION BETWEEN CORONARY HEART DISEASE PREVALENCE AND AT… (10.15829/1728-8800-2013-3-50-54)
Abstract ORCID
38.91 5
23 RUSSIAN VERSION OF PHQ-2 AND 9 QUESTIONNAIRES: SENSITIVITY A… (10.15829/1728-8800-2014-3-18-24)
ORCID
38.91 35
24 THE INFLUENCE OF PATHOLOGICAL CARDIO-ANKLE VESSEL INDEX ON A… (10.15829/1728-8800-2015-3-18-24)
Abstract ORCID
38.91 5
25 XXXI RUSSIAN NATIONAL CONGRESS "MAN AND MEDICINE". APRIL 15-… (10.15829/1728-8800-2024-6s)
References ORCID
38.91 5
26 What factors do influence arterial hypertension control in R… (10.15829/1728-8800-2018-4-53-60)
Abstract
38.29 33
27 Comorbidity, multimorbidity, dual diagnosis — synonyms or di… (10.15829/1728-8800-2019-2-65-69)
Abstract
36.18 27
28 Hospital register of patients with acute cerebrovascular acc… (10.15829/1728-8800-2018-6-32-38)
Abstract
35.78 26
29 RESTENOSIS RISK FACTORS AFTER CORONARY ARTERY STENTING IN OB… (10.15829/1728-8800-2013-3-4-9)
Abstract ORCID
34.95 4
30 RISK FACTOR PREVALENCE AND PROBABILITY OF FATAL CARDIOVASCUL… (10.15829/1728-8800-2016-4-38-43)
Abstract ORCID
34.95 4
31 Prospective in-hospital registry of patients with suspected… (10.15829/1728-8800-2020-2727)
Abstract
34.95 24
32 Subclinical atherosclerosis as a risk factor of cardiovascul… (10.15829/1728-8800-2012-3-82-86)
ORCID
34.51 23
33 Focused vascular ultrasound. Consensus of Russian experts (10.15829/1728-8800-2022-3333)
Abstract
34.04 22
34 Vascular ageing: main symptoms and mechanisms (10.15829/1728-8800-2012-4-93-100)
ORCID
33.56 21
35 MORTALITY AND LOST YEARS OF LIFE AS A RESULT OF CARDIOVASCUL… (10.15829/1728-8800-2014-2-4-11)
ORCID
33.06 20
36 SOCIO-ECONOMIC EFFECTIVENESS OF HEALTH SCREENING ACTIVITY IN… (10.15829/1728-8800-2014-3-4-10)
ORCID
32.53 19
37 Prevention of noncommunicable diseases as an opportunity to… (10.15829/1728-8800-2019-2-5-12)
Abstract
31.97 18
38 Economic damage of risk factors associated with morbidity an… (10.15829/1728-8800-2020-1-48-55)
Abstract
31.97 18
39 Secondary prevention in patients with coronary artery diseas… (10.15829/1728-8800-2020-2739)
Abstract
31.97 18
40 Russian mortality trends in the early XXI century: official… (10.15829/1728-8800-2011-6-5-10)
ORCID
31.38 17
41 The outpatient medical care in patients with chronic disease… (10.15829/1728-8800-2021-3172)
ORCID
31.38 17
42 The impact of comorbidities and age on the nosocomial outcom… (10.15829/1728-8800-2019-2-58-64)
Abstract
30.76 16
43 DETECTION OF DIABETES MELLITUS IN THE OLDER POPULATION OF A… (10.15829/1728-8800-2013-4-36-40)
Abstract ORCID
30.10 3
44 EVALUATION OF AN INTERRELATION OF TARGET BLOOD PRESSURE ACHI… (10.15829/1728-8800-2014-6-23-27)
ORCID License
30.10 3
45 LIPID PEROXIDATION AND THE LEVEL OF FREE FATTY ACIDS IN PATI… (10.15829/1728-8800-2015-2-25-30)
Abstract ORCID
30.10 3
46 CLINICAL CHARACTERISTICS OF ISCHEMIC HEART DISEASE PATIENTS… (10.15829/1728-8800-2015-3-25-29)
Abstract ORCID
30.10 3
47 ATYPICAL CLINICAL COURSE OF THE ACUTE MYOCARDIAL INFARCTION:… (10.15829/1728-8800-2016-4-10-15)
Abstract ORCID
30.10 3
48 AN OBESE PATIENT “PORTRAIT” BY THE RESULTS OF OUTPATIENT CAR… (10.15829/1728-8800-2016-4-44-49)
Abstract ORCID
30.10 3
49 Strategies for the prevention of chronic non-communicable di… (10.15829/1728-8800-2019-4-92-98)
Abstract
30.10 15
50 XXVIII RUSSIAN NATIONAL CONGRESS “MAN AND MEDICINE”. COLLECT… (10.15829/1728-8800-2021-1s)
References ORCID
30.10 3